COMP <GO>
CPSH vs PG // GROSS PROFIT MARGIN
CPS Technologies Corp. (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: CPSH 2
— PG 10
▲ GROSS PROFIT MARGIN LEADER: PG
LAST: $3.54 (-1.39%) • MKT CAP: $69.6M
gross-margins
16.20%
LAST: $163.56 (+1.23%) • MKT CAP: $374.48B
gross-margins
51.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPSH VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPSH | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 16.20% | 51.20% | -35.00 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.70% | 25.40% | -23.70 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 64.4x | 16.2x | +48.20 | PG | /valuation <GO> |
| Free Cash Flow Yield | -0.67% | 3.77% | -4.44 | PG | /fcf-yield <GO> |
| Operating Margin | 1.40% | 24.30% | -22.90 | PG | /operating-margins <GO> |
| Net Profit Margin | 1.30% | 19.00% | -17.70 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 54.30% | 0.30% | +54.00 | CPSH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.76 | 5.59 | +4.17 | CPSH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 62.0 | -15.50 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $69.6M | $374.48B | -$374.41B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPSH REV | PG REV | CPSH GROSS % | PG GROSS % | CPSH FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $32.6M | $84.28B | 16.2% | 51.2% | -$487.0K | $14.04B |
| FY 2024 | $21.1M | $84.04B | -0.6% | 51.4% | -$4.5M | $16.52B |
| FY 2023 | $27.6M | $82.01B | — | — | $1.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPSH // BETA —
PG // BETA 0.87